Keita Hamamatsu

First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [18F]FB(ePEG12)12-Exendin-4: A Phase 1 Clinical Study Targeting GLP-1 Receptor Expression Cells in Pancreas

Hiroyuki Fujimoto, Naotaka Fujita, Keita Hamamatsu et al. · Frontiers in Endocrinology · 2021 · 26 citations · Full text

Synthesis and biological evaluation of an 111In-labeled exendin-4 derivative as a single-photon emission computed tomography probe for imaging pancreatic β-cells

Hiroyuki Kimura, Naotaka Fujita, Kaori Kanbe et al. · Bioorganic & Medicinal Chemistry · 2017 · 20 citations

111In-labeled Exendin-4 Derivative, Tissue Imaging, Engineering +8

Development of 111In-labeled exendin(9-39) derivatives for single-photon emission computed tomography imaging of insulinoma

Hiroyuki Kimura, Hirokazu Matsuda, Yu Ogawa et al. · Bioorganic & Medicinal Chemistry · 2017 · 19 citations

Evaluation of 18F-labeled exendin(9-39) derivatives targeting glucagon-like peptide-1 receptor for pancreatic β-cell imaging

Hiroyuki Kimura, Yu Ogawa, Hiroyuki Fujimoto et al. · Bioorganic & Medicinal Chemistry · 2017 · 18 citations

Glucagon-like Peptide-1 Receptor, Signal Transduction, Pancreatic Cancer +9

Noninvasive Evaluation of GPR119 Agonist Effects on β-Cell Mass in Diabetic Male Mice Using 111In-Exendin-4 SPECT/CT

Takaaki Murakami, Hiroyuki Fujimoto, Naotaka Fujita et al. · Endocrinology · 2019 · 18 citations